Subscribe to PLMJ’s newsletters to receive the most up-to-date legal insights and our invitations to exclusive events.
Subscribe to PLMJ’s newsletters to receive the most up-to-date legal insights and our invitations to exclusive events.
«A process wich involves removal of a stem cell from a human embryo at the blastocyst stage, entailing the destruction of that embryo, cannot be patented. The use of human embryos for therapeutic or diagnostic purposes which are applied to the human embryo and are use ful to it is patentable, but their use for purposes of scientific research is not patentable.»